Here Are Some Essential Facts About Philip Morris International

By Chris Stiles • Saturday, January 11 15:13 • Permanent Link

Philip Morris International sank -3.9% today, compared to the S&P 500's day change of -2.0%. Today's losers may turn out to be tomorrow's winners, so be sure to check the stock's fundamentals before making an investment decision:

Philip Morris International has moved 24.0% over the last year, and the S&P 500 logged a change of 22.3%
PM has an average analyst rating of buy and is -13.57% away from its mean target price of $135.54 per share
Its trailing earnings per share (EPS) is $6.3
Philip Morris International has a trailing 12 month Price to Earnings (P/E) ratio of 18.6 while the S&P 500 average is 29.3
Its forward earnings per share (EPS) is $7.2 and its forward P/E ratio is 16.3
Philip Morris International is part of the Consumer Defensive sector, which has an average P/E ratio of 23.09 and an average P/B of 3.3
PM has reported YOY quarterly earnings growth of 49.3% and gross profit margins of 0.6%
The company has a free cash flow of $9.21 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris International Inc. was incorporated in 1987 and is headquartered in Stamford, Connecticut.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.